Cytori Therapeutics Inc Stock price Nasdaq
Equities
US23283K4022
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 3.4M | Sales 2025 * | 4.28M | Capitalization | 7.91M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -22M | EV / Sales 2024 * | 2.33 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.85 x |
P/E ratio 2024 * |
-0.81
x | P/E ratio 2025 * |
-0.98
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.77% |
Latest transcript on Cytori Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 20-02-05 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Richard Hawkins
CHM | Chairman | 75 | 07-11-30 |
Robert Lenk
BRD | Director/Board Member | 75 | 20-02-29 |
1st Jan change | Capi. | |
---|---|---|
+9.16% | 45.97B | |
+53.46% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |